Alagille syndrome (AGS) is an autosomal dominant disease characterized by five major abnormalities in the liver, heart, face, vertebrae and eye. The responsible gene has been recently identified as the human Jagged 1 (JAG1) gene, which encodes a ligand for the Notch receptor. We analyzed the JAG1 gene in eight AGS families, including affected and unaffected individuals, at the genomic DNA level, mainly by singlestrand conformational polymorphism (SSCP) and DNA sequencing analysis. Four categories of mutations were identified: (i) four frameshift mutations in exons 9, 22, 24 and 26 were exhibited respectively in affected individuals of four AGS families, which resulted in moving the translational frame of JAG1; (ii) one nonsense mutation, a 1 bp substitution in exon 5 of the EGF-like repeat domain, was detected in two unrelated AGS families, which altered codon 235 from arginine to stop; (iii) one acceptor splice site mutation of exon 5 was revealed in a sporadic patient; and (iv) a 1.3 Mb deletion, which included the entire JAG1 gene, was found in another patient. Our results further demonstrate that AGS is a dominant disease and suggest that the JAG1 gene exerts a fundamental role in regulating genes involved in development.
INTRODUCTION
Alagille syndrome (AGS; MIM 118450), first described in 1975, occurs in 1/70 000-100 000 live births and is one of the important causes of intrahepatic cholestasis in infancy. Affected individuals are usually characterized by paucity of interlobular bile ducts, characteristic facies, peripheral pulmonary artery stenosis, butterfly-like vertebral anomalies and posterior embryotoxon (1, 2) . The clinical phenotype of AGS patients shows highly variable expressivity, from asymptomatic to severe cases who require liver transplantation.
Genetic studies have demonstrated that AGS is an autosomal dominant disease with 94% penetrance and 15% sporadic occurrence (3) . Based on karyotype observations in multiple AGS patients with deletions or translocations, the AGS gene was first mapped to the short arm of chromosome 20, as only monosomy is associated with the phenotypic abnormalities (4) (5) (6) (7) (8) (9) (10) . However, the fact that most patients have normal karyotypes suggested that mutations in a single gene may be the primary cause of this disorder (11) (12) (13) (14) .
Combined with molecular studies of deletions in chromosome 20p from AGS patients, the AGS locus was mapped to the region between D20S5 and D20S42. A 3.7 Mb YAC clone contig was constructed and five CpG islands were discovered in this candidate region for the AGS gene (15) . The other results of molecular analysis in two AGS patients with a balanced translocation or submicroscopic deletion also demonstrated a 1.3 Mb critical region within a YAC clone contig (10, 13) . Recently, this critical region has been further narrowed to 250 kb by one group studying the AGS gene. They focused on a CpG island and finally identified a human homolog of rat Jagged 1 (JAG1) which encodes a ligand for the Notch1 receptor (16, 17) . Another research group took a different approach. They isolated the human JAG1 gene first and mapped it to chromosome 20p12, to which AGS is linked, then hypothesized that JAG1 may be the gene responsible for AGS based on the known function of Notch genes. Several mutations in human JAG1 have been confirmed in AGS families, indicating that it is a critical gene for AGS (17, 18) .
We analyzed the JAG1 gene in eight AGS families, mainly by single-strand conformational polymorphism (SSCP) and DNA sequencing, at the genomic level and identified seven mutations of the JAG1 gene that were present in affected individuals of our AGS families. The majority of these mutations have not been reported before. This result further demonstrates that the human JAG1 gene is the gene responsible for AGS.
RESULTS
Twenty-six exons of the JAG1 gene were analyzed at the genomic level in eight AGS families. The mutation analysis and identification were mainly performed by SSCP and DNA sequencing in all family members, except for one case with a visible deletion (U3) by Southern blotting and densitometric analysis. Of the eight AGS families in this study, six abnormal JAG1 genes were obviously inherited from affected parents and the other two mutations appeared to be sporadic. Seven mutations, divided into four categories, are summarized in Table 1 
Frameshift mutations
In family S5 the father and two children had the same aberrant band in exon 9 by SSCP analysis. Genomic DNA sequencing showed a single A insertion at position 1665, which led to a translational frameshift and produced a truncated protein with an altered region of 12 amino acids and a premature stop codon in the EGF-like repeat domain of JAG1 (Fig. 1a) . The phenotypes of the affected members in this family were different from each other, although the mutation was obviously transmitted from the father to the two children. The father was a sub-clinical case with mild γ-glutamyltransferase elevation, heart murmur and an atypical face, but had no abnormal complaints before his children were diagnosed with AGS. The children, however, were typical AGS cases with chronic cholestasis, peripheral pulmonary arterial stenosis, posterior embryotoxon of the eye and Alagille facies. Another 1 bp insertion (T) mutation was detected in family N3. The mutation was identified at position 3067 of exon 22, changing codon 878 from an asparagine to a stop in the cysteine-rich (CR) domain. The abnormal JAG1 transcript was deleted of most of the CR domain and the transmembrane (TM) domain. In this family, the affected father was an asymptomatic AGS case with an atypical face only, but the proband apparently suffered from AGS disease with severe hepatogenic cholestasis and other abnormalities (Fig. 1b) .
Two fraternal twin boys in family O4 were diagnosed as AGS patients. Although both of them suffered from five major abnormalities and growth retardation, the clinical features were different from each other. In particular, one proband was severely compromised with cholestasis, while the other was affected by extreme tetralogy of Fallot syndrome and died at the age of three as a consequence of heart failure. The father was a sub-clinical AGS case and the mother had normal status. After analysis of the JAG1 gene, a novel mutation in exon 26 was confirmed in the three affected members only. A 2 bp (CT) deletion at position 3683 changed the following translational codons, with 33 different amino acids and a stop codon after the CR domain (Fig. 1c) .
Mutation analysis of the JAG1 gene in family Y3 demonstrated a 2 bp (TA) insertion at position 3495 in exon 24, changing codon 1036 from isoleucine to stop. The JAG1 transcript lost the TM domain. This mutation existed in both the affected mother and proband, indicating a familial inheritance mode. The father was normal status and did not have the same mutation of the JAG1 gene as judged by SSCP and DNA sequencing analysis (Fig. 1d ).
Nonsense mutation
The same nonsense mutation was detected in two unrelated AGS families (D3 and E3). In family D3, the father and proband revealed the same mutation, but the mother was normal. However, in family E3, only the proband had the same mutation as that in family D3, while the father and mother did not show any abnormalities (data not shown). The mutation was located in exon 5 and was characterized as a 1 nt change (C!T) at position 1162 of JAG1 (Fig. 1e ). As this substitution altered an arginine codon to a stop codon, the JAG1 transcript was very short, containing only a complete DSL domain and five amino acids of the EGF-like repeat region.
Splice site mutation
A novel band was found by SSCP and demonstrated as a splice site mutation at the acceptor splice site of exon 5 by genomic DNA sequencing. This mutation was only present in an AGS girl of family A4. The parents and elder brother were normal and did not show the same abnormality in mutation analysis. The substitution AG→GG at position 1154-2 of exon 5 changed the conservative constitution at the intron-exon junction, causing loss of a restriction enzyme site (Fig. 1f) . Based on mutation studies involving the splice site (19, 20) , exon skipping could be predicted.
Large deletion
The proband of family U3 was a typical AGS patient and his karyotype showed a visible deletion of 20p11.23-12.1. We screened a YAC library with 12 allele markers and two STS markers and constructed a YAC contig in the deletion region based on linkage analysis (21) (22) (23) (24) (25) (26) (27) . Genotype analysis of this AGS case indicated a one allele region from D20S175 to D20S58 which was significantly different from that in other AGS patients and normal individuals. It indicated that part of this region may not be homozygous but hemizygous. Haplotype inheritance analysis in two other AGS families with two affected children (S5 and O4) revealed a common region from D20S188 to D20S61 for the AGS gene, which was located in the one allele region. We thus hypothesized that the overlapping region is a real candidate region for the AGS gene, which was mapped to two entire overlapping YAC clones (791E9 and 742F5). Many probes were produced by subcloning EcoRI fragments from the two YAC clones, and were arranged in each marker segment of the candidate region by dot blotting with another six overlapping YAC clones in this region. We then checked the break-point of the deletion in this patient by Southern blotting and densitometric analysis and finally identified a 1.3 Mb deletion region from D20S507 to D20S61 containing the JAG1 gene (Fig. 2) . This large deletion in the proband may be inherited from his affected father, who had an atypical face and mild abnormal liver function, however, the father refused to undergo further examination. This patient suffered from severe cholestasis and a subacute failure of liver function and had been accepted for liver transplantation. His severe phenotype may, at the very least, be associated with the loss of other related segments, besides the JAG1 gene, within this large deleted region.
DISCUSSION
Eight families with a diagnosis of AGS disease in our study were analyzed for mutations in the JAG1 gene at the genomic DNA level. Seven mutations, belonging to four categories, were identified mainly by SSCP and DNA sequencing. All of the mutations, except a large deletion in one AGS patient, were newly detected. They were located in five exons and apparently affected the EGF-like repeat and CR and TM domains. To date, combining our data with other mutations of the JAG1 gene in two published papers (17, 18) , a total of 19 mutations has been identified. The majority are frameshift mutations (11/19), followed by splice site mutations (4/19), nonsense mutations (2/19) and a large deletion (2/19). The point mutations occurred in 10 exons (4-6, 11-13, 22-24 and 26) associated with the EGF-like repeat and CR region and, possibly, the Delta/Serrate/Lag-2 (DSL) region. Mutations located in the TM region have not yet been discovered. In our study, two fraternal twin children in family O4 had inherited the same mutation from the father and undergone the same intra-uterine conditions of development but had different phenotypes. The only hypothesis is that the pathogenesis of AGS involves the regulation of other genes, besides JAG1, or that expression of the mutant JAG1 gene was affected by different maternal genes. However, if this condition occurred in identical twins, environment factors might be important in modifying expression of the JAG1 gene. There were three mutations in exon 5, two of which are identical and existed in two unrelated AGS families with different inheritance patterns, familial in family D3 and sporadic in family E3. Since exon 5 is a small exon with only 61 bp, this phenomenon might suggest a mutation hotspot for the JAG1 gene in this region. A final conclusion can be made only after analysis of many mutations of the JAG1 gene in cases of AGS. It could also be that these two apparently unrelated families share a common ancestor.
The human JAG1 gene has a very important function in development. Expression analysis of JAG1 by northern blotting indicated that it is extensively expressed in various tissues of the adult and in some tissues of the fetus. It is already known that the JAG1 gene encodes a ligand for the Notch receptor which is vertically inserted in the cell membrane and is divided into two parts, extracellular and intracellular. Both regions contain conserved domains. This molecular structure suggests that Notch signaling may be directly transmitted from the cell surface to the nucleus and control cell fate during development, especially in precursor cell progress to a more differentiated state (28, 29) . Pathogenesis caused by targeted disruption of the Notch family has already been demonstrated in some disorders of humans and animals (30) (31) (32) . Although it has been confirmed that AGS is caused by mutations of the JAG1 gene, we do not know why these mutations only affect specific organs in AGS patients, since JAG1 protein is widely presented in many tissues. It is obvious that the different mutation patterns of the JAG1 gene are not related to the phenotype of AGS patients, because variable manifestations in affected members of an AGS family result from the same mutation. As the ligand encoded by the JAG1 gene has been considered to have a fundamental effect in transmission of Notch signaling, we think that this is probably due to redundancy of multiple Notch ligands, such as Jagged 2, which shows an overlapping expression pattern with JAG1 in some tissues. Thus, cooperation with other Notch gene family members in specific tissues and different stages of embryonic development may result in different pathological disorders.
At present, we do not know the exact correlation between mutations of the JAG1 gene and AGS phenotype. The different mutation patterns and translational isoproteins are apparently not associated with clinical features in AGS patients in the present study. In view of the loss of one JAG1 allele in AGS patients with a visible deletion, haplo-insufficiency of JAG1 is considered to be one important cause of AGS. This probable cause of AGS has also been supported by the observation that a patient with a point mutation in the JAG1 gene lacks expression of the mutant allele (17) . However, most patients with point mutations could generate both normal and abnormal JAG1 protein. If the aberrant JAG1 has no biological function it may act in a dominant negative manner, so that the result is similar to haplo-insufficiency. The third possibility is dosage-dependent efficiency of the JAG1 protein, as the aberrant proteins of variable size have different degrees of biological function, as animal studies have revealed that Notch is very sensitive to gene dosage. On the basis of studies on co-expression of Jagged and Notch (28, 29) , we conclude that although the mutations in the JAG1 gene are responsible for AGS, its expression pattern might suggest that JAG1 exerts a fundamental role in gene regulation, probably associated with the Notch family.
MATERIALS AND METHODS

Patients and families with AGS
Our study covered seven unrelated two generation families and one three generation family that included a total of 28 individuals. All 10 probands met the criteria of typical AGS (1). Affected parents, except an asymptomatic father in family N3, were sub-clinical AGS cases; the AGS diagnosis was made only after the probands had been diagnosed as AGS and then traced back to their parents (Table 2) . A liver biopsy was performed for all patients to confirm the diagnosis. The pathological characteristics, as in previous reports, revealed significant intrahepatic biliary hypoplasia in which the ratio of bile ducts per portal triad was <0.5 (0.9-1.8 in normal individuals). Other abnormalities were biliary epithelial vacuolization, irregularity and mild inflammatory infiltration in the portal areas and intrahepatic cholestasis, giant cell transformation and even fibrosis in some cases of longer duration (33) (34) (35) (36) . Karyotype analysis of metaphase lymphocytoblasts revealed a visible deletion involving 20p11.23-p12.1 in the proband of family U3.
SSCP analysis
Genomic DNA was isolated from leukocytes or established cell lines of affected and unaffected members in each AGS family and unrelated individuals as a control by the standard method of phenol and chloroform extraction. A total of 31 primer pairs was used to amplify the complete coding region of the JAG1 gene; 59 primer sequences followed a published report (17) while three oligonucleotide primers for exons 1 and 2 were selected by us (Table 3) according to the published sequence of JAG1. PCR reactions were carried out by a radioactive procedure using [α-32 P]dATP (Amersham, UK) with reaction parameters as follows: 1 min at 94_C denaturation, 1 min at 60_C annealing and 2 min at 72_C extension, with a final 10 min extension, for a total of 30 cycles. Exons 1 and 2 of the JAG1 gene were amplified under different conditions, as shown in Table 3 . After denaturation, the PCR products were loaded into the slots of a 5% SSCP gel containing 5% glycerol. The running conditions were 250 and 1000 V, respectively, with 1× TBE buffer at room temperature. The results were analyzed by Fujix Bastation v.1.2 in an Image Analyzer (FuJiPhoto Film, Japan).
DNA sequencing
After a novel SSCP band was identified, a PCR reaction was performed under the same conditions as for SSCP analysis. The DNA products were purified by low melting point agarose electrophoresis and the GELase method, following the protocol of Epicentre Technologies. These purified DNAs were used for direct DNA sequencing with the same primers as in the SSCP analysis, labeled with [γ-32 P]dATP by T4 polynucleotide kinase, and/or SmaI-digested pUC 18 -cloned DNA sequencing with primer M4 internally labeled with [α-32 P]dATP by Thermo Sequenase. DNA sequencing was carried out with a Thermo Sequenase Cycle Sequencing Kit (Amersham Life Science, Arlington Heights, IL) according to the manufacturer's protocol with some modification for the ASTEC automatic PCR programer (ASTEC, Japan). Sequence analysis was carried out under the same conditions as for the SSCP study. b The prime sequence was based on a published paper (18) .
Mutation analysis
The human JAG1 cDNA and human JAG1 protein sequences were taken from DDBJ/EMBL/GenBank (accession no. AF003837) and a published paper (16) . Mutation analysis of JAG1 was performed using GENETYX-Mac v.8.0 software. Novel mutations were finally identified after verification by several criteria, including: (i) that the mutation existed in every affected member in an AGS family; (ii) that the mutation produced an aberrant JAG1 protein as assumed by computer analysis; and (iii) that the mutation in sporadic cases could be checked by direct DNA sequencing and cloned DNA sequencing using different PCR products in order to avoid artificial mutations caused by the PCR reaction.
Southern blotting and densitometric analysis
The same amount (3 µg) of genomic DNA from an AGS patient with a deletion (U3) and a control were digested with EcoRI, HindIII, PstI and XbaI and run on a 0.7% agarose gel at 20 V overnight and then were blotted onto a nylon filter by a capillary method. A target probe against a critical region of the AGS gene and a control probe produced from chromosome 1 were simultaneously applied in the Southern hybridization. The band densities of both the patient and the control were checked by densitometric analysis in an Image Analyzer. When the results showed that the patient had only half the copy number of the control in the target bands, this indicated that the probe was located in the deleted region; however, if the bands of the patient and the control showed the same density, this indicated that the probe was located outside the deletion. The same filter was rehybridized with another target probe and the densitometric analysis repeated only after being stripped (Fig. 2) .
